Delivery Order SPE2DE23D0008-SPE2D625F1NWH
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $2,814 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to supply Natrelle Inspira SSM 405cc breast implants. Performance will occur at Allergan's facility in Irvine, California, with no set-aside designation applied. As a sole-source provider of proprietary breast implant products, Allergan will deliver the devices to support reconstructive surgeries at military treatment facilities. This award is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,092.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division for Inspira SRLP 205CC breast implants. The award, made on September 11, 2025, with an ultimate completion date of September 22, 2025, represents a child delivery order under one of Allergan's larger Indefinite Delivery Vehicle contracts for Natrelle breast implants and surgical devices valued at $13.5 million. The contract utilizes...
- The U.S. Department of Defense Medical Supply Chain, operating through the Defense Logistics Agency Troop Support Medical, awarded a $2,814 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCX 800cc breast implants. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 25, 2025, represents a child order under one of Allergan's existing Indefinite Delivery Vehicles—specifically a $13.5 million IDV for...
- This federal contract award is for the delivery of Natrelle Inspira SCF 385CC breast implants to the U.S. government. The $2,607.00 fixed-price delivery order was awarded to Allergan USA Inc., a subsidiary of AbbVie Inc., by the Defense Logistics Agency Troop Support Medical. The contract has an ultimate completion date of July 2, 2025 and does not utilize a set-aside designation. Allergan USA Inc. is a leading medical device and pharmaceutical company that specializes in the production of...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F1NWHDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $3,021 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SCF 415CC breast implants. The contract, which carries no set-aside designation, reflects Allergan's status as a sole-source provider of specialized reconstructive and aesthetic surgical devices to the federal government. The award is structured as a fixed-price contract with economic price adjustment, with performance scheduled for completion by August 25, 2025, and execution from the company's facility in Irvine, California. This delivery order falls under one of two significant Indefinite Delivery Vehicles established between Allergan USA Inc. and DLA Troop Support Medical on December 8, 2022—specifically the $13.5 million IDV for Natrelle breast implants and surgical devices. The underlying contract vehicles, which feature one-year base periods with four one-year option periods, enable the electronic ordering and fulfillment of Allergan's breast implant products across Department of Defense research centers, hospitals, and clinics. These contracts support reconstructive and aesthetic surgical procedures at military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers, providing critical medical technologies to military members, veterans, and Native American populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/21/25 |